Common use of Xxxxxxxx Xxxxxx Clause in Contracts

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30, 2020 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Shares, no par value per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. a Canadian corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o) of the Equity Distribution Agreement, dated June 30, 2020 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X.Xxxxxxxx@xxx.xxx​Xxx XxxxxxXxxxxx.X.Xxxxxx@xxx.xxx​Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx DateXxxxxxxXxx.X.Xxxxxxx@xxx.xxx​Xxxxxxx Rice & Company L.L.C ​Attention: Subject​Xxxxxxx Xxxxxxxxxxxx@xxxx.xxx ​Xxxxxx Xxxxxxxxxxxxxxxx@xxxx.xxx ​Xxxxxx XxxxxxxXxxxxxx@xxxx.xxx ​ Date:​Subject: [●[ ⚫ ], 20[●] [ ⚫ ]​Amended and Restated Equity Distribution Agreement – Placement Notice Gentlemen: ​ Pursuant to the terms and subject to the conditions contained in the Amended and Restated Equity Distribution Agreement between IMV among Independence Contract Drilling, Inc. ( (“Company”), and Xxxxx Xxxxxxx ​ ​ ​ & Co. ( and Xxxxxxx Xxxx & Company L.L.C. (“AgentAgents”) dated June 30August 19, 2020 2021, (the “Agreement”), the Company hereby requests that Agent Agents sell up to [●[ ⚫ ] Common Sharesshares of the Company’s common stock, no par value $0.01 per share, at a minimum market price of U.S. $[●[ ⚫ ] per share. Sales should begin on the date of this Placement Notice and shall continue until [●[ ⚫ ] /[all shares are sold]. ​ ​ ​ ​ ​ ​ SCHEDULE 2 ​ NOTICE PARTIES IMV ​ ​ ​ Independence Contract Drilling, Inc. Xxxxxx Xxxxx 000 ​ Xxxxxxx Xxxxxxxx xxxxxxxxx@xxxxxxxxxx.xxx ​ Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxxx@xxxxxxxxxx.xxx ​ Xxxxxxxxx Xxxxxxx xxxxxxxx@xxxxxxxxxx.xxx ​ ​ ​ Xxxxx Xxxxxxx & Co. ​ Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. a Canadian corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o) of the Equity Distribution Agreement, dated June 30, 2020 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:Xxxx.X.Xxxxx@xxx.xxx ​

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Aravive, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30March 26, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all •]/[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Aravive, Inc. Xxxxxx Xxx Xxxxxxx, Chief Executive Officer xxxxxxxx@xxxxxxx.xxx Xxxxx 000 Xxxxxx Xxxxxx AvenueXxxx, Suite 19 DartmouthChief Financial Officer xxxxx@xxxxxxx.xxx Xxxxx Xxxx, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Vice President/Finance and Principal Accounting Officer xxxxx@xxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date•], 20[•] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. Aravive, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30March 26, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Aptevo Therapeutics Inc. – Equity Distribution Agreement – Placement Notice Ladies and Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement Agreement, dated November 9, 2017 (the “Agreement”), between IMV Aptevo Therapeutics Inc. ( (the “Company”), ) and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30, 2020 (the “AgreementAgent”), the Company hereby requests that the Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all •]/[all such shares are sold]. Schedule 1 US-DOCS\95271282.8 SCHEDULE 2 NOTICE PARTIES IMV Aptevo Therapeutics Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxx@xxxx.xxx Jeff Lamothe xxxxxxx@xxxx.xxx Xxxxxxx Xxxxxxxx xxxxxxxxx@xxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Schedule 2 US-DOCS\95271282.8 SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 SirLadies and Gentlemen: The undersigned, the duly qualified and elected [•], of IMV Inc. Aptevo Therapeutics Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30November [•], 2020 2017 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Subject: Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Aquestive Therapeutics, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30September 11, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Aquestive Therapeutics, Inc. Xxxxxx Xxxxx 000 X. Xxxxxxx xxxxxxxx@xxxxxxxxx.xxx Xxxx X. Xxxxxxx xxxxxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 XXxxxxx@xxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•●], of IMV Inc. Aquestive Therapeutics, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify certify, solely in such capacity and on behalf of the CompanyCompany and not in his individual capacity, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30September 11, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx XxxxxxXxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx XxxxxxxXxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Evofem Biosciences, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30November 18, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Evofem Biosciences, Inc. Xxxxxxx Xxxxxxxxx, Chief Executive Officer Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx AvenueX. File, Suite 19 DartmouthChief Financial Officer Xxxxxxxxx X. Xxxxxxxxxxx, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 General Counsel Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. Evofem Biosciences, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30November 18, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●[ ● ], 20[●[ ● ] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Endologix, Inc. ( (“Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30August 13, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●[ ● ] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●[ ● ] per share. Sales should begin on the date of this Placement Notice and shall continue until [●[ ● ] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Endologix, Inc. Xxxx Xxxxxxxxxx, Chief Executive Officer xxxxxxxxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxx 000 Xxxxxxx, Chief Financial Officer xxxxxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxxx AvenueXxxxxx, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 General Counsel xxxxxxx@xxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date[ ● ], 20[ ● ] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•[ ● ], of IMV Inc. Endologix, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30August 13, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Inc. ( (“Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30March [●], 2020 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Shares, no par value per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. a Canadian corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o) of the Equity Distribution Agreement, dated June 30March 18, 2020 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Inhibikase Therapeutics, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30May 16, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●[ ] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●[ ] per share. Sales should begin on the date of this Placement Notice and shall continue until [●[ ] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Inhibikase Therapeutics, Inc. Xxxxxx Xxxxx 000 X. Xxxxxx, Ph.D. Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 X. Xxxxxxxxxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•[ ], of IMV Inc. Inhibikase Therapeutics, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30May 16, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●Date] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Arvinas, Inc. ( (the “Company”), ) and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30October 1, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●] per share. Sales should may begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]sold].1 1 Additional limitations or parameters to be specified in any individual Placement Notice as applicable. SCHEDULE 2 NOTICE PARTIES IMV Arvinas, Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxx X. Houston Xxxx.Xxxxxxx@xxxxxxx.xxx Xxxx Xxxxxxx Xxxx.Xxxxxxx@xxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•]●] of Arvinas, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), does hereby certify certify, solely in such capacity and on behalf of the CompanyCompany and not in his individual capacity, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30October 1, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx XxxxxxXxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx XxxxxxxXxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Subject: Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV POINT Biopharma Global Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30July 1, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] ]/[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV POINT Biopharma Global Inc. Xxxx Xxxxxx xxxxxxx@xxxxxxxxxxxxxx.xxx Xxx XxXxxx xxxxxxx@xxxxxxxxxxxxxx.xxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxxx@xxxxxxxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. POINT Biopharma Global Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30July 1, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Subject: Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Inc. ( XBiotech Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June April 30, 2020 2019 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [[●] /[all ], 20[●]/[all shares are sold]]. Schedule 1 SCHEDULE 2 NOTICE PARTIES IMV XBiotech Inc. Xxxx Xxxxxx, Chief Executive Officer xxxxxxx@xxxxxxxx.xxx Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx AvenueXxx, Suite 19 DartmouthVice President, Nova ScotiaFinance and Human Resources, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 and Secretary xxxx@xxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date●], 20[●] Xxxxx Xxxxxxx XXXXX XXXXXXX & Co. CO. U.S. Bancorp Center 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX Xxxxxxxxx 00000 SirLadies and Gentlemen: The undersigned, the duly qualified and elected [•●], of IMV Inc. XBiotech Inc., a Canadian corporation company incorporated under the laws of the Province of British Columbia (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June April 30, 2020 2019 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV U.S. Well Services, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30April 26, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s Class A common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV U.S. Well Services, Inc. Xxxx X’Xxxxx xxxxxxx@xxxxxxxxxxxxxx.xxx Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxxxx xxxxxxxx@xxxxxxxxxxxxxx.xxx Xxxx Xxxxxxxx xxxxxxxxx@xxxxxxxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Xxx Xxxxx Xxx.Xxxxx@xxxxxxxxxx.xxx Xxxxxxx Xxxxxxx Xxxxxxx.Xxxxxxx@xxx.xxx Schedule 2 SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o4(h) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 SirSir or Madam: The undersigned, the duly qualified and elected [•]Chief Executive Officer and the duly qualified and elected Chief Financial Officer of U.S. Well Services, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), does do hereby certify in such capacity and on behalf of the Company, and not in any individual capacity, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30April 26, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Catalyst Biosciences, Inc. ( (the “Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30October 15, 2020 2021 (the “Agreement”), the Company hereby requests that Agent sell up to [●[ ] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●[ ] per share. Sales should begin on the date of this Placement Notice and shall continue until [●[ ] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Catalyst Biosciences, Inc. Xxxxxx Xxxxx 000 Nassim Usman xxxxxx@xxxxxx.xxx Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxxx@xxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•●], of IMV Inc. Catalyst Biosciences, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30October 15, 2020 2021 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxxxxxx Xxx.Xxxxxxx@xxx.xxx Xxxx Xxxxx Xxxx.Xxxxx@xxx.xxx Xxxxxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement by and between IMV TELA Bio, Inc. ( (“Company”), ) and Xxxxx Xxxxxxx & Co. ( (“Agent”) ), dated June 30November 13, 2020 2023 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV TELA Bio, Inc. Xxxxxx Xxxxxxx xxxxxxxx@xxxxxxx.xxx Xxxxxxx Xxxx xxxxx@xxxxxxx.xxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxxxx xxxxxxxx@xxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxxx Xxxx.Xxxxx@xxx.xxx Connor Xxxxxx X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxxxxxx Xxx.Xxxxxxx@xxx.xxx Xxxx Xxxxx Xxxx.Xxxxx@xxx.xxx Xxxxxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date●] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx800 Nicollet Mall Minneapolis, XX 00000 MN 55402 Sir/Madam: The undersigned, the duly qualified and elected [•]Chief Operating Officer and Chief Financial Officer of TELA Bio, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30November 13, 2020 2023 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: [•], 20[•] Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Cytek Biosciences, Inc. ( (“Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30August 26, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Cytek Biosciences, Inc. Xxxxxx Xxxxx 000 xxxxxx@xxxxxxxx.xxx Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxxxxxx xxxxxxxxxx@xxxxxxxx.xxx Xxxxxxx Xxxxxxx xxxxxxxx@xxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Xxxxxx X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o) [3(q)] OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•]Chief Executive Officer or Chief Financial Officer of Cytek Biosciences, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30August 26, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV ChemoCentryx, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30December 4, 2020 2018 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV ChemoCentryx, Inc. Xxxxxx X. Xxxxxx, Ph.D. XXxxxxx@xxxxxxxxxxxx.xxx Xxxxx 000 X. Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 XXxxxxx@xxxxxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date•], 20[•] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. ChemoCentryx, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30December 4, 2020 2018 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Subject: Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV KLX Energy Services Holdings, Inc. ( “Company”), ) and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 3014, 2020 2021 (the “Agreement”), the Company hereby requests that the Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.01 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV KLX Energy Services Holdings, Inc. Xxxxxx Xxxxxxxxxxx Xxxxx 000 xxxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxxx@xxxxxxxxx.xxx Xxx Xxxxxxxxxxxx xxxx@xxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date●], 20[●] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 SirSir or Madam: The undersigned, the duly qualified and elected [•●], of IMV Inc. KLX Energy Services Holdings, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 3014, 2020 2021 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that he or she has carefully examined the Registration Statement, the Prospectus, and any Permitted Free Writing Prospectus, and any amendments thereof or supplements thereto (including any documents filed under the Exchange Act and deemed to be incorporated by reference into the base prospectus, the Prospectus and any Permitted Free Writing Prospectus), and to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement Agreement, dated June 11, 2018 (the “Agreement”), between IMV Alpine Immune Sciences, Inc. ( (the “Company”), ) and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30, 2020 (the “AgreementAgent”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all such shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Alpine Immune Sciences, Inc. Xxxxxxxx Gold xxxxx@xxxxxxxxx.xxx Xxxx Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxx.xxxxxx@XxxxxxXxxxxxXxxxxxxx.xxx Xxxxxxx Xxxxxxxxx xxxxxxx.xxxxxxxxx@xxxxxxxxxxxxxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxx.X.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxxxxx.X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o5(H) OF THE EQUITY DISTRIBUTION AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. Alpine Immune Sciences, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o5(h) of the Equity Distribution Agreement, dated June 3011, 2020 2018 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30August 4, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Shares, no par value per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Inc. Xxxxxx Xxxxx Xxxxxxxx Xxxxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•[ • ], of IMV Inc. a Canadian corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o) of the Equity Distribution Agreement, dated June 30August 4, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: [•], 20[•] Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Codexis, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30May 7, 2020 2021 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●•] /[all / [all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Codexis, Inc. Xxxx Xxxxxx Xxxxx 000 xxxx.xxxxxx@xxxxxxx.xxx Xxxx Xxxxxx xxxx.xxxxxx@xxxxxxx.xxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 XxxXxxxxx Xxxxxx.xxxxxxxxx@xxxxxxx.xxx Xxxxxxx Sabalot Xxxxxxx.xxxxxxx@xxxxxxx.xxx Xxxxxxxx Xxxxxx xxxxxxxx.xxxxxx@xxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•]Chief Executive Officer and Chief Financial Officer of Codexis, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), does do hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30May 7, 2020 2021 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx JonesTrading Institutional Services LLC Xxx Xxxxx xxxx@xxxxxxxxxxxx.xxx Xxxxx Xxxxxx xxxxxxx@xxxxxxxxxxxx.xxx Xxxx X’Xxxxxxxx xxxxx@xxxxxxxxxxxx.xxx Xxxx Xxxxxx xxxxx@xxxxxxxxxxxx.xxx Xxxx Xxxxxxx xxxxxxxx@xxxxxxxxxxxx.xxx Burke Cook xxxxx@xxxxxxxxxxxx.xxx With a copy to XXXX@Xxxxxxxxxxxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV among Day One Biopharmaceuticals, Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( (“AgentPiper”) and JonesTrading Institutional Services LLC (“JonesTrading”), dated June 301, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell [Piper/JonesTrading] sells up to [●] Common Sharesshares of the Company’s common stock, no par value $0.0001 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Day One Biopharmaceuticals, Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 xxxxxx.xxxxxx@xxxxxxxxx.xxx Xxxxxxx Xxxx II xxxxxxx.xxxx@xxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx JonesTrading Institutional Services LLC Xxx Xxxxx xxxx@xxxxxxxxxxxx.xxx Xxxxx Xxxxxx xxxxxxx@xxxxxxxxxxxx.xxx Xxxx X’Xxxxxxxx xxxxx@xxxxxxxxxxxx.xxx Xxxx Xxxxxx xxxxx@xxxxxxxxxxxx.xxx Xxxx Xxxxxxx xxxxxxxx@xxxxxxxxxxxx.xxx Burke Cook xxxxx@xxxxxxxxxxxx.xxx With a copy to XXXX@Xxxxxxxxxxxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 SirJonesTrading Institutional Services LLC 000 Xxxx 00xx Xxxxxx, 00xx Xxxxx Xxx Xxxx, XX 00000 Sirs and Madams: The undersigned, the duly qualified and elected [•●], of IMV Inc. Day One Biopharmaceuticals, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 301, 2020 2022 (the “Equity Distribution Agreement”), between among the Company and Company, Xxxxx Xxxxxxx & Co.Co. and JonesTrading Institutional Services LLC, that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Miromatrix Medical Inc. ( “Company”), and Xxxxx Xxxxxxx & Co. ( “Agent”) dated June 30July, 2020 1, 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●] Common Sharesshares of the Company’s common stock, no par value $0.00001 per share, at a minimum market price of U.S. $[●] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Miromatrix Medical Inc. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx AvenueXxxx Xxxx, Suite 19 DartmouthCEO xxxxx@xxxxxxxxxx.xxx Xxx Xxxxxxx, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 CFO xxxxxxxx@xxxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Xxxxxxx X. Bassett Xxxxxxx.Xxxxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•]Chief Executive Officer and Chief Financial Officer, of IMV Inc. Miromatrix Medical Inc., a Canadian Delaware corporation (the “Company”), does hereby certify in such capacity and on behalf of the Company, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30July 1, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx X.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxxxxx.X.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxx.X.Xxxxxxx@xxx.xxx Date: Subject: [●•], 20[●20[•] Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV Fulcrum Therapeutics, Inc. ( (“Company”), and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30May 9, 2020 2022 (the “Agreement”), the Company hereby requests that Agent sell up to [●•] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●•] per share. Sales should begin on the date of this Placement Notice and shall continue until [●] /[all •]/[all shares are sold]. SCHEDULE 2 NOTICE PARTIES IMV Fulcrum Therapeutics, Inc. Bryan Stuart xxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxx 000 Xxxxxxxx xxxxxxxxx@xxxxxxxxx.xxx Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxxxx xxxxxxxx@xxxxxxxxx.xxx Xxxx Xxxxxxxxxx xxxxxxxxxxx@xxxxxxxxx.xxx Xxxxx Xxxxxxx & Co. Xxxxxxx Xxxxxxx Xxxxxxx.Xxxxxxx@xxx.xxx Xxxx X. Riley Xxxxx Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxx Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxxxxxx Xxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(Q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The undersigned, the duly qualified and elected [•], of IMV Inc. Fulcrum Therapeutics, Inc., a Canadian Delaware corporation (the “Company”), does hereby certify solely in such capacity and on behalf of the CompanyCompany and not in his individual capacity, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30May 9, 2020 2022 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned:

Xxxxxxxx Xxxxxx. Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxxxxxx Xxx. Xxxxxxx@xxx.xxx Xxxxxxx Xxxxxxx Xxxxxxx.Xxxxxxx@xxx.xxx Date: Subject: [●], 20[●] Subject: Equity Distribution Agreement – Placement Notice Gentlemen: Pursuant to the terms and subject to the conditions contained in the Equity Distribution Agreement between IMV VIVUS, Inc. ( (“Company”), ) and Xxxxx Xxxxxxx & Co. ( (“Agent”) dated June 30March 6, 2020 (the “Agreement”), the Company hereby requests that Agent sell up to [●¨] Common Sharesshares of the Company’s common stock, no par value $0.001 per share, at a minimum market price of U.S. $[●¨] per share. Sales should begin on [the date of this Placement Notice Notice]/[¨] and shall continue until [●¨] /[all / [all such shares are sold]sold].1 1 Additional parameters may be included in accordance with Section 2(a)(i) of the Agreement. SCHEDULE 2 NOTICE PARTIES IMV VIVUS, Inc. Xxxx Xxxx Xxxx X. Oki Xxxx X. Xxxxxx Xxxxx 000 Xxxxxx Xxxxxx Avenue, Suite 19 Dartmouth, Nova Scotia, Canada B3B 2C4 Telephone: +0 (000) 000-0000 Facsimile: +0 (000) 000-0000 Xxxxx Xxxxxxx & Co. Xxxx X. Riley Xxxx.Xxxxx@xxx.xxx Connor X. Xxxxxxxx Xxxxxx.Xxxxxxxx@xxx.xxx Xxx Xxxxxx Xxxxxx.Xxxxxx@xxx.xxx Xxx X. Hershey Xxx.Xxxxxxx@xxx.xxx Xxxxxxx Xxxxxxx Xxxxxxx.Xxxxxxx@xxx.xxx SCHEDULE 3 FORM OF REPRESENTATION CERTIFICATE PURSUANT TO SECTION 4(o3(q) OF THE AGREEMENT [Date] Xxxxx Xxxxxxx & Co. 000 800 Xxxxxxxx Xxxx Xxxxxxxxxxx, XX 00000 Sir: The Each of the undersigned, the duly qualified and elected [•]] or [•] of VIVUS, of IMV Inc. Inc., a Canadian Delaware corporation (the “Company”), as applicable, does hereby certify certify, solely in such capacity and on behalf of the Company, and not in any individual capacity, pursuant to Section 4(o3(q) of the Equity Distribution Agreement, dated June 30March 6, 2020 (the “Equity Distribution Agreement”), between the Company and Xxxxx Xxxxxxx & Co., that to the best of the knowledge of the undersigned: